References
- HeckAMYanovskiJACalisKAOrlistat, a new lipase inhibitor for the management of obesityPharmacotherapy200020327027910730683
- MoralesPFujioSNavarretePImpact of dietary lipids on colonic function and microbiota: an experimental approach involving orlistat-induced fat malabsorption in human volunteersClin Transl Gastroenterol201674e16127054579
- PozzaCIsidoriAMWhat’s Behind the Obesity Epidemic Imaging in Bariatric SurgeryNew YorkSpringer International Publishing AG201818
- AungKLorenzoCHinojosaMAHaffnerSMRisk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individualsJ Clin Endocrinol Metab201499246246824257907
- KushnerRFWeight loss strategies for treatment of obesityProg Cardiovasc Dis201456446547224438739
- DolencAGovedaricaBDreuRKocbekPSrcicSKristlJNanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibitionInt J Pharm20103961–214915520540997
- MenendezJAVellonLLupuRAntitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogeneAnn Oncol20051681253126715870086
- PandeyHCRadhakrishnanRBMohammedSFVaghelaDNarayanaRGLINVENTIS DDS PVT LtdPharmaceutical composition of orlistatUS Patent2010Application No 12/738 145
- LindenmüllerIHLambrechtJTOral careTopical Applications and the MucosaBaselKarger Publishers201140107115
- GadeMMHurkadalePJFormulation and evaluation of self-emulsifying orlistat tablet to enhance drug release and in vivo performance: factorial design approachDrug Deliv Transl Res20166327628827037924
- SangwaiMSardarSVaviaPNanoemulsified orlistat-embedded multi-unit pellet system (MUPS) with improved dissolution and pancreatic lipase inhibitionPharm Dev Technol2014191314123259606
- MadhavKVKishanVSelf microemulsifying particles of loratadine for improved oral bioavailability: preparation, characterization and in vivo evaluationJ Pharm Investig2018484497508
- KumarASharmaSKambleRSelf emulsifying drug delivery system (SEDDS): future aspectsInt J Pharm Pharm Sci201024713
- NarangASDelmarreDGaoDStable drug encapsulation in micelles and microemulsionsInt J Pharm20073451–292517945446
- NazzalSKhanMAControlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parametersInt J Pharm20063151–211012116563673
- AhsanMNVermaPRPEnhancement of in vitro dissolution and pharmacodynamic potential of olanzapine using solid SNEDDSJ Pharm Investig2018483269278
- SeoYGKimDHRamasamyTDevelopment of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effectInt J Pharm20134521–241242023707964
- BalakrishnanPLeeBJEnhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS)Eur J Pharm Biopharm200972353954519298857
- FolchJLeesMSloane StanleyGHA simple method for the isolation and purification of total lipids from animal tissuesJ Biol Chem1957226159750913438845
- FengJZhangQLiuQZhuZApplication of nanoemulsions in formulation of pesticidesMcClementsDJJafariSMNanoemulsionsCambridgeAcademic Press2018379413
- InugalaSEedaraBBSunkavalliSSolid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: in vitro and in vivo evaluationEur J Pharm Sci20157411025845633
- ZhuangCYLiNWangMPreparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailabilityInt J Pharm20103941–217918520471464
- MohsinKShahbaAAAlanaziFKLipid based self emulsifying formulations for poorly water soluble drugs-an excellent opportunityInd J Pharm Edu Res20124628896
- MadhavKVKishanVSelf microemulsifying particles of loratadine for improved oral bioavailability: preparation, characterization and in vivo evaluationJ Pharm Investig2018484497508